Conferences  >  Medicine & Healthcare  >  Continuing Medical Education (CME)  >  Belgium

Bioevents Ltd

We would like to invite you to attend The 3rd International Conference on Controversies in Neuropathic Pain, taking place 20-21 November 2023 in Brussels, Belgium. Following the success of the virtual conference last year, we are delighted to announce that we will once again be convening in person to engage in stimulating discussions on the most pressing and controversial issues surrounding neuropathic pain. This conference is intended to gather clinicians, translational and basic scientists who have an interest in neuropathic pain, with the aim of discussing important areas within the field. These areas will range from the clinical aspects of diagnosis, classification, and neurophysiology, to the molecular mechanisms and genetics involved in neuropathic pain. The conference will offer a platform for established researchers and junior investigators to network, collaborate and develop new research partnerships. Junior researchers will have the opportunity to present their work and receive feedback from leading experts in the field.

Phone: [00442030514032];     Email: ilana@bioevents-congress.com

Preclinical research, pain, neuropathic, genetics, pain classification (ICD-11), Assesment, Diagnosis, Measurement of Pain, Peripheral Neuropathic pain, Central neuropathic pain, Neuroimaging, Psychology, Pharmacology, Clincial Trials, Controversies, neuroimaging

Medicine (in general), Internal medicine,    Traditional and Alternative Medicine

Bioevents Ltd

It is with great pleasure that we invite you to join us in person at The 4th European Congress on Controversies in Leukemia (Euroleuk2023) which will take place 20-21 November 2023 in Brussels, Belgium. The diagnosis and treatment of acute and chronic leukemia are changing dramatically. In recent years, numerous new drugs have entered the market, changing the prognosis of leukemia patients. In this context, a continuous exchange among peers, together with the opportunity to hear the most important news from the voices of Europe’s leading key opinion leaders, is essential to ensure the best level of care for leukemia patients. The all-new format will feature debate-style presentations on hot topics in acute and chronic leukemia, with speakers presenting contrasting views to stimulate interactive discussion with faculty and attendees. Euroleuk2023 will continue to provide clinicians and biologists with the latest recommendations for patient care, as well as insights into controversies and new therapeutic perspectives in the field.

Phone: [00442030514032];     Email: ilana@bioevents-congress.com

acute myeloid leukemia, AML, acute lymphoblastic leukemia, ALL, chronic lymphocytic leukemia (CLL), stem cell transplantation, leukemia, leukaemia, treatment, immunotherapy, clincial, biology, diagnosis, ELN2022, WHO2022,

Oncology,    Stem-cell Research & Therapy